GLOBAL LIQUID BIOPSY MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

GLOBAL LIQUID BIOPSY MARKET 2021-2028

Market by Clinical Application, Therapeutic Application, Biomarker Type, Analysis Platform, Analysis Purpose, Product, Industry Verticals, and Geography | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research’s detailed analysis of the global liquid biopsy market denotes that, based on revenue, the market is envisioned to grow at a CAGR of 18.54% during the forecasting years 2021-2028. In 2020, the market garnered $1179.1 million, and is projected to attain $4759.0 million by 2028. 


Report scope can be customized per your requirements. Request For Customization

Liquid biopsy is a non-invasive medical procedure that can detect the presence of molecular cancer biomarkers in biological fluids. The derived test results help the medical professional decide the further steps in the treatment of cancer patients.

The liquid biopsy technique is based on capturing and analyzing the tumor-derived particles, including nucleic acids, nucleosomes, exosomes, proteins, and cells. The two main characteristics of malignant tumor cells are rapid cell division and metastasis. Hence, finding traces of their existence in the body fluids is possible with the help of analytical approaches with high sensitivity (NGS or digital PCR). Thus, a liquid biopsy test enables non-invasive real-time cancer screening and treatment monitoring. 

Triton’s study aims to get an overview of the liquid biopsy market in terms of various factors. Within this report, the key insight and the market summary regarding the market have been discussed. Besides, the Impact of COVID-19 on the liquid biopsy market; Porter’s five forces model; market attractiveness matrix; initiatives pertaining to liquid biopsy; legal, policy, & regulatory framework; vendor scorecard; and key market strategies have been studied comprehensively.

Furthermore, market drivers such as the high prevalence of cancer in the geriatric population, the growing importance of liquid biopsy testing, and government initiatives are driving the expansion of the studied market. Also, the advancement in technologies, untapped diagnostic testing opportunities in developing nations, and consumer demand for diagnostic centers are significant factors that the market can leverage to accomplish the projected growth.

However, key market restraints, such as lack of reimbursement for liquid biopsy, disadvantages associated with compensation, shortage of skilled professionals, and elevated cost of the test, are impeding the global liquid biopsy market’s growth.



Major geographies covered in the liquid biopsy market by region are:

•           North America: Canada and United States

•           Europe: Russia, Spain, United Kingdom, Germany, France, Italy, and Rest of Europe

•           Asia-Pacific: Australia & New Zealand, Japan, India, ASEAN countries, South Korea, China, and Rest of Asia-Pacific

•           Latin America: Mexico, Brazil, and Rest of Latin America

•           Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa, and Rest of Middle East & Africa

The global liquid biopsy market is segmented into:

•           Market by Clinical Application:

           o          Treatment Monitoring

           o          Prognosis and Reoccurrence Monitoring

           o          Treatment Selection

           o          Diagnosis and Screening

•           Market by Therapeutic Application:

           o          Lung Cancer

           o          Breast Cancer

           o          Prostate Cancer

           o          Colorectal Cancer

           o          Melanoma Cancer

           o          Other Types of Cancer

           o          Non-Oncology Application

•           Market by Biomarker Type:

           o          Nucleic Acid

           o          Protein

           o          Extracellular Vesicles

           o          Cells

•           Market by Analysis Platform:

           o          NGS

           o          Microarray

           o          PCR

           o          Proteomics

           o          Other Analysis Platforms

•           Market by Analysis Purpose:

           o          Early Detection/Screening

           o          Therapy Guidance

           o          Monitoring

           o          Diagnosis

•           Market by Product:

           o          Circulating Tumor DNA (CTDNA)

           o          Circulating Tumor Cells (CTCS)

           o          Cell-Free DNA (CFDNA)

           o          Extracellular Vesicles and Others

•           Market by Industry Verticals:

           o          Physicians’ Office Laboratories

           o          Hospitals

           o          Clinical Diagnostic Laboratories

The reputed enterprises in the liquid biopsy market include Bio-Rad Laboratories Inc, Qiagen NV, Illumina Inc, F Hoffmann-La Roche, Agilent Technologies Inc, Adaptive Biotechnologies, Menarini-Silicon Biosystems, Grail, Becton Dickinson and Company (BD), Myriad Genetics Inc, Foundation Medicine, MDxHealth SA, Thermo Fisher Scientific Inc, Angle Plc, Natera, Guardant Health Inc, Personal Genome Diagnostics, and Biocept Inc.         

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. GLOBAL LIQUID BIOPSY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON LIQUID BIOPSY MARKET

2.2. KEY INSIGHTS

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. INITIATIVES PERTAINING TO LIQUID BIOPSY

2.5. LEGAL, POLICY, & REGULATORY FRAMEWORK

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS AND PARTNERSHIP

2.8.2. BUSINESS EXPANSION, ANNOUNCEMENTS, AND DIVESTITURES

2.8.3. ACQUISITIONS & MERGERS

2.8.4. NEW PRODUCT LAUNCHES

2.9. MARKET DRIVERS

2.9.1. HIGH PREVALENCE OF CANCER IN GERIATRIC POPULATION

2.9.2. GROWING IMPORTANCE OF LIQUID BIOPSY TESTING

2.9.3. RISING GOVERNMENT INITIATIVES

2.10. MARKET RESTRAINTS

2.10.1. LACK OF REIMBURSEMENT FOR LIQUID BIOPSY

2.10.2. DISADVANTAGES ASSOCIATED WITH COMPENSATION

2.10.3. UNAVAILABILITY OF SKILLED PROFESSIONALS

2.10.4. HIGH COST OF LIQUID BIOPSY TEST

2.11. MARKET OPPORTUNITIES

2.11.1. ADVANCEMENT IN TECHNOLOGIES

2.11.2. UNTAPPED DIAGNOSTIC TESTING OPPORTUNITIES IN DEVELOPING COUNTRIES

2.11.3. GROWING DEMAND FOR DIAGNOSTIC CENTERS

3. GLOBAL LIQUID BIOPSY MARKET - BY CLINICAL APPLICATION

3.1. TREATMENT MONITORING

3.2. PROGNOSIS AND REOCCURRENCE MONITORING

3.3. TREATMENT SELECTION

3.4. DIAGNOSIS AND SCREENING

4. GLOBAL LIQUID BIOPSY MARKET - BY THERAPEUTIC APPLICATION

4.1. LUNG CANCER

4.2. BREAST CANCER

4.3. PROSTATE CANCER

4.4. COLORECTAL CANCER

4.5. MELANOMA CANCER

4.6. OTHER TYPES OF CANCER

4.7. NON-ONCOLOGY APPLICATION

5. GLOBAL LIQUID BIOPSY MARKET - BY BIOMARKER TYPE

5.1. NUCLEIC ACID

5.2. PROTEIN

5.3. EXTRACELLULAR VESICLES

5.4. CELLS

6. GLOBAL LIQUID BIOPSY MARKET - BY ANALYSIS PLATFORM

6.1. NGS

6.2. MICROARRAY

6.3. PCR

6.4. PROTEOMICS

6.5. OTHER ANALYSIS PLATFORMS

7. GLOBAL LIQUID BIOPSY MARKET - BY ANALYSIS PURPOSE

7.1. EARLY DETECTION/SCREENING

7.2. THERAPY GUIDANCE

7.3. MONITORING

7.4. DIAGNOSIS

8. GLOBAL LIQUID BIOPSY MARKET - BY PRODUCT

8.1. CIRCULATING TUMOR DNA (CTDNA)

8.2. CIRCULATING TUMOR CELLS (CTCS)

8.3. CELL-FREE DNA (CFDNA)

8.4. EXTRACELLULAR VESICLES AND OTHERS

9. GLOBAL LIQUID BIOPSY MARKET - BY INDUSTRY VERTICALS

9.1. PHYSICIANS’ OFFICE LABORATORIES

9.2. HOSPITALS

9.3. CLINICAL DIAGNOSTIC LABORATORIES

10. GLOBAL LIQUID BIOPSY MARKET – REGIONAL OUTLOOK

10.1. NORTH AMERICA

10.1.1. COUNTRY ANALYSIS

10.1.1.1. UNITED STATES

10.1.1.2. CANADA

10.2. EUROPE

10.2.1. COUNTRY ANALYSIS

10.2.1.1. UNITED KINGDOM

10.2.1.2. FRANCE

10.2.1.3. GERMANY

10.2.1.4. ITALY

10.2.1.5. RUSSIA

10.2.1.6. SPAIN

10.2.1.7. REST OF EUROPE

10.3. ASIA-PACIFIC

10.3.1. COUNTRY ANALYSIS

10.3.1.1. JAPAN

10.3.1.2. CHINA

10.3.1.3. INDIA

10.3.1.4. SOUTH KOREA

10.3.1.5. AUSTRALIA & NEW ZEALAND

10.3.1.6. ASEAN COUNTRIES

10.3.1.7. REST OF ASIA-PACIFIC

10.4. LATIN AMERICA

10.4.1. COUNTRY ANALYSIS

10.4.1.1. BRAZIL

10.4.1.2. MEXICO

10.4.1.3. REST OF LATIN AMERICA

10.5. MIDDLE EAST AND AFRICA

10.5.1. COUNTRY ANALYSIS

10.5.1.1. SAUDI ARABIA

10.5.1.2. UNITED ARAB EMIRATES

10.5.1.3. TURKEY

10.5.1.4. SOUTH AFRICA

10.5.1.5. REST OF MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

11.1. ADAPTIVE BIOTECHNOLOGIES

11.2. AGILENT TECHNOLOGIES INC

11.3. ANGLE PLC

11.4. BECTON DICKINSON AND COMPANY (BD)

11.5. BIOCEPT INC

11.6. BIO-RAD LABORATORIES INC

11.7. F HOFFMANN-LA ROCHE

11.8. FOUNDATION MEDICINE

11.9. GRAIL

11.10. GUARDANT HEALTH INC

11.11. ILLUMINA INC

11.12. MDXHEALTH SA

11.13. MENARINI-SILICON BIOSYSTEMS

11.14. MYRIAD GENETICS INC

11.15. NATERA

11.16. PERSONAL GENOME DIAGNOSTICS

11.17. QIAGEN NV

11.18. THERMO FISHER SCIENTIFIC INC

12. RESEARCH METHODOLOGY & SCOPE

12.1. RESEARCH SCOPE & DELIVERABLES

12.1.1. OBJECTIVES OF STUDY

12.1.2. SCOPE OF STUDY

12.2. SOURCES OF DATA

12.2.1. PRIMARY DATA SOURCES

12.2.2. SECONDARY DATA SOURCES

12.3. RESEARCH METHODOLOGY

12.3.1. EVALUATION OF PROPOSED MARKET

12.3.2. IDENTIFICATION OF DATA SOURCES

12.3.3. ASSESSMENT OF MARKET DETERMINANTS

12.3.4. DATA COLLECTION

12.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       GLOBAL LIQUID BIOPSY MARKET, BY REGION, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       LIST OF CONTRACTS AND PARTNERSHIP

TABLE 4:       LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

TABLE 5:       LIST OF ACQUISITIONS & MERGERS

TABLE 6:       LIST OF NEW PRODUCT LAUNCHES

TABLE 7:       GOVERNMENT INITIATIVES PERTAINING TO CANCER AND LIQUID BIOPSY IN SOME COUNTRIES

TABLE 8:       GLOBAL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 9:       GLOBAL LIQUID BIOPSY MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 10:     GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER TYPE, 2021-2028 (IN $ MILLION)

TABLE 11:     GLOBAL LIQUID BIOPSY MARKET, BY ANALYSIS PLATFORM, 2021-2028 (IN $ MILLION)

TABLE 12:     GLOBAL LIQUID BIOPSY MARKET, BY ANALYSIS PURPOSE, 2021-2028 (IN $ MILLION)

TABLE 13:     GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 14:     GLOBAL LIQUID BIOPSY MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

TABLE 15:     GLOBAL LIQUID BIOPSY MARKET, BY REGION, 2021-2028 (IN $ MILLION)

TABLE 16:     NORTH AMERICA LIQUID BIOPSY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 17:     EUROPE LIQUID BIOPSY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 18:     ASIA-PACIFIC LIQUID BIOPSY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 19:     LATIN AMERICA LIQUID BIOPSY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 20:     MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     GLOBAL LIQUID BIOPSY MARKET, BY REGION, 2021-2028 (IN $ MILLION)

FIGURE 2:     GLOBAL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2020 & 2028 (IN %)

FIGURE 3:     GLOBAL LIQUID BIOPSY MARKET, BY TREATMENT MONITORING, 2021-2028 (IN $ MILLION)

FIGURE 4:     GLOBAL LIQUID BIOPSY MARKET, BY PROGNOSIS AND REOCCURRENCE MONITORING, 2021-2028 (IN $ MILLION)

FIGURE 5:     GLOBAL LIQUID BIOPSY MARKET, BY TREATMENT SELECTION, 2021-2028 (IN $ MILLION)

FIGURE 6:     GLOBAL LIQUID BIOPSY MARKET, BY DIAGNOSIS AND SCREENING, 2021-2028 (IN $ MILLION)

FIGURE 7:     GLOBAL LIQUID BIOPSY MARKET, BY THERAPEUTIC APPLICATION, 2020 & 2028 (IN %)

FIGURE 8:     GLOBAL LIQUID BIOPSY MARKET, BY LUNG CANCER, 2021-2028 (IN $ MILLION)

FIGURE 9:     GLOBAL LIQUID BIOPSY MARKET, BY BREAST CANCER, 2021-2028 (IN $ MILLION)

FIGURE 10:  GLOBAL LIQUID BIOPSY MARKET, BY PROSTATE CANCER, 2021-2028 (IN $ MILLION)

FIGURE 11:  GLOBAL LIQUID BIOPSY MARKET, BY COLORECTAL CANCER, 2021-2028 (IN $ MILLION)

FIGURE 12:  GLOBAL LIQUID BIOPSY MARKET, BY MELANOMA CANCER, 2021-2028 (IN $ MILLION)

FIGURE 13:  GLOBAL LIQUID BIOPSY MARKET, BY OTHER TYPES OF CANCER, 2021-2028 (IN $ MILLION)

FIGURE 14:  GLOBAL LIQUID BIOPSY MARKET, BY NON-ONCOLOGY APPLICATION, 2021-2028 (IN $ MILLION)

FIGURE 15:  GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER TYPE, 2020 & 2028 (IN %)

FIGURE 16:  GLOBAL LIQUID BIOPSY MARKET, BY NUCLEIC ACID, 2021-2028 (IN $ MILLION)

FIGURE 17:  GLOBAL LIQUID BIOPSY MARKET, BY PROTEIN, 2021-2028 (IN $ MILLION)

FIGURE 18:  GLOBAL LIQUID BIOPSY MARKET, BY EXTRACELLULAR VESICLES, 2021-2028 (IN $ MILLION)

FIGURE 19:  GLOBAL LIQUID BIOPSY MARKET, BY CELLS, 2021-2028 (IN $ MILLION)

FIGURE 20:  GLOBAL LIQUID BIOPSY MARKET, BY ANALYSIS PLATFORM, 2020 & 2028 (IN %)

FIGURE 21:  GLOBAL LIQUID BIOPSY MARKET, BY NGS, 2021-2028 (IN $ MILLION)

FIGURE 22:  GLOBAL LIQUID BIOPSY MARKET, BY MICROARRAY, 2021-2028 (IN $ MILLION)

FIGURE 23:  GLOBAL LIQUID BIOPSY MARKET, BY PCR, 2021-2028 (IN $ MILLION)

FIGURE 24:  GLOBAL LIQUID BIOPSY MARKET, BY PROTEOMICS, 2021-2028 (IN $ MILLION)

FIGURE 25:  GLOBAL LIQUID BIOPSY MARKET, BY OTHER ANALYSIS PLATFORMS, 2021-2028 (IN $ MILLION)

FIGURE 26:  GLOBAL LIQUID BIOPSY MARKET, BY ANALYSIS PURPOSE, 2020 & 2028 (IN %)

FIGURE 27:  GLOBAL LIQUID BIOPSY MARKET, BY EARLY DETECTION/SCREENING, 2021-2028 (IN $ MILLION)

FIGURE 28:  GLOBAL LIQUID BIOPSY MARKET, BY THERAPY GUIDANCE, 2021-2028 (IN $ MILLION)

FIGURE 29:  GLOBAL LIQUID BIOPSY MARKET, BY MONITORING, 2021-2028 (IN $ MILLION)

FIGURE 30:  GLOBAL LIQUID BIOPSY MARKET, BY DIAGNOSIS, 2021-2028 (IN $ MILLION)

FIGURE 31:  GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT, 2020 & 2028 (IN %)

FIGURE 32:  GLOBAL LIQUID BIOPSY MARKET, BY CIRCULATING TUMOR DNA (CTDNA), 2021-2028 (IN $ MILLION)

FIGURE 33:  GLOBAL LIQUID BIOPSY MARKET, BY CIRCULATING TUMOR CELLS (CTCS), 2021-2028 (IN $ MILLION)

FIGURE 34:  GLOBAL LIQUID BIOPSY MARKET, BY CELL-FREE DNA (CFDNA), 2021-2028 (IN $ MILLION)

FIGURE 35:  GLOBAL LIQUID BIOPSY MARKET, BY EXTRACELLULAR VESICLES AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 36:  GLOBAL LIQUID BIOPSY MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)

FIGURE 37:  GLOBAL LIQUID BIOPSY MARKET, BY PHYSICIANS’ OFFICE LABORATORIES, 2021-2028 (IN $ MILLION)

FIGURE 38:  GLOBAL LIQUID BIOPSY MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 39:  GLOBAL LIQUID BIOPSY MARKET, BY CLINICAL DIAGNOSTIC LABORATORIES, 2021-2028 (IN $ MILLION)

FIGURE 40:  GLOBAL LIQUID BIOPSY MARKET, BY REGION, 2020 & 2028 (IN %)

FIGURE 41:  UNITED STATES LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 42:  CANADA LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 43:  UNITED KINGDOM LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 44:  FRANCE LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 45:  GERMANY LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 46:  ITALY LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 47:  RUSSIA LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 48:  SPAIN LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 49:  REST OF EUROPE LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 50:  JAPAN LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 51:  CHINA LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 52:  INDIA LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 53:  SOUTH KOREA LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 54:  AUSTRALIA & NEW ZEALAND LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 55:  ASEAN COUNTRIES LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 56:  REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 57:  BRAZIL LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 58:  MEXICO LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 59:  REST OF LATIN AMERICA LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 60:  SAUDI ARABIA LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 61:  UNITED ARAB EMIRATES LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 62:  TURKEY LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 63:  SOUTH AFRICA LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

FIGURE 64:  REST OF MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;